Cogent Biosciences, Inc. (NASDAQ:COGT) has 261 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 2,605,056 | 25.12% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 678,704 | 3.03% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -213,908 | -39.94% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 3,756,664 | 48.43% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -1,720,949 | -21.82% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 650 | 0.00% | $0.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Dec, 2025 | 0 | -9,215 | -0.10% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | -930,000 | -13.68% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 4,124,755 | 118.96% | $0.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 0 | -390,144 | -13.99% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 164,881 | 3.45% | $0.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 0 | -524,111 | -18.24% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 1,359,365 | 42.77% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | -5,053,155 | -69.70% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 240,407 | 7.34% | $0.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 0 | -2,000,000 | -50.00% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 2,305,437 | 566.59% | $0.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 0 | -154,316 | -7.25% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 716,879 | 46.83% | $0.00 |